Small airway disease with air trapping appears to be a long-lasting sequela of SARS-CoV-2 infection, according to a prospective study that compared 100 COVID-19 survivors who had persistent symptoms and 106 healthy control persons. “Something is going on in the distal airways related to either inflammation or fibrosis that is […]
Survival after in-hospital cardiac arrest was roughly one-third lower in patients with COVID-19 infections compared to uninfected patients, based on data from nearly 25,000 individuals. Survival rates of less than 3% were reported in the United States and China for patients who suffered in-hospital cardiac arrest (IHCA) while infected with […]
Before March 2020, many people saw pandemics as a thing of the past. Then came COVID-19. Scientists still do not know exactly where the virus that caused it — SARS-CoV-2 — came from, but it soon reached almost every country worldwide. Over 2 years, the virus has evolved, producing several […]
New research suggests that alpha-1 antitrypsin could be an effective option for treating those with COVID-related acute respiratory distress syndrome (ARDS). In their study, published in the journal Med, researchers from RCSI University of Medicine and Health Sciences and Beaumont Hospital Dublin investigated the effects of using the anti-inflammatory protein alpha-1 antitrypsin […]
The mRNA COVID-19 vaccines produced better antibody response in human milk from lactating women compared with the adenovirus vector-based vaccines, results from a Dutch study suggested. Almost all lactating women who received either the Pfizer-BioNTech (96%) or Moderna (97%) mRNA vaccines had detectable IgA antibodies in their milk, reported Hannah […]
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines. NIAID is sponsoring the study, called HVTN 302, […]
Un estudio realizado por el área de Enfermedades Infecciosas del CIBER (CIBERINFEC) en el Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC) ha identificado los primeros casos de hepatitis aguda en Europa provocados por el Orthohepevirus C, un nuevo virus de origen zoonótico. Los investigadores señalan que esto puede suponer una nueva causa emergente de hepatitis aguda en Europa debido a la prevalencia detectada entre pacientes con hepatitis aguda de origen desconocido. Antonio Rivero, investigador del CIBERINFEC, de […]
El CEO de Pfizer, Albert Bourla, indicó en una entrevista en el programa Face the Nation de CBS, que por cuestiones de seguridad y para poder obtener una mayor protección contra el COVID-19 y todas sus variantes será necesaria una cuarta dosis de la vacuna de su laboratorio. Pfizer presentará a la FDA datos sobre […]
China reported 1,800 new symptomatic COVID-19 cases on Sunday, representing the highest daily figure in two years and more than triple the number from the day before, according to Reuters. On Saturday, the country’s National Health Commission reported 476 cases, which included 114 people initially classified as asymptomatic who later developed […]
The true death toll from the coronavirus pandemic may be more than three times higher than official records suggest, researchers said. Instead of the official estimate of 5.9 million COVID-related deaths, a more realistic estimate is 18.2 million, according to a report in The Lancet. Researchers compared data from 74 […]
